PHARMACEUTICAL TECHNOLOGY CENTRE LTD

Registered number: 14341407

	2025	2024
	£	£
Fixed assets	520	1,088

Current assets	162,353	160,360
Creditors: Amounts Falling Due Within One Year	(2,165 )	(43,175 )

NET CURRENT ASSETS	160,188	117,185

TOTAL ASSETS LESS CURRENT LIABILITIES	160,708	118,273

Creditors: Amounts Falling Due After More Than One Year	(51,819 )	-
Accruals and deferred income	-	(244 )

NET ASSETS	108,889	118,029

CAPITAL AND RESERVES	108,889	118,029

Notes

1. General Information

PHARMACEUTICAL TECHNOLOGY CENTRE LTD is a private company, limited by shares, incorporated in England & Wales, registered number 14341407 . The registered office is Daresbury Laboratory Sci-Tech Daresbury, Daresbury, Warrington, WA4 4AD.

2. Average Number of Employees

Average number of employees, including directors, during the year was: 1 (2024: 1)

3. Post Balance Sheet Events

Reduction in Share Capital

The directors have resolved to reduce the company's share capital in the next financial year ending 30 Septmeber 2026. This decision was made after the reporting date of these financial statements and is subject to the necessary legal and procedural requirements. The reduction in share capital does not affect the company’s ability to continue as a going concern.

4. Going Concern

The directors will continue to adopt the going concern basis in preparing the financial statements which assumes that the company will continue in operation for the foreseeable future.

Page 0

Page 1

PHARMACEUTICAL TECHNOLOGY CENTRE LTD

Balance Sheet (continued)

As At 30 September 2025

For the year ending 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

On behalf of the board

S I Qanadilo

Director

19/05/2026